Search

everythinglearnresearchcommunity

for

Search:↓

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

CYP2B12 enzyme in skin cells converts arachidonic acid into specific bioactive lipids.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

No link found between aromatase gene and female hair loss.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

1α,25-dihydroxyvitamin D3 directly affects cartilage growth and development.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

A genetic marker linked to a type of hair loss was found in most patients studied.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.